Atlas Trials

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Clinical trial NCT02097875 · COMPLETED

Trial details

NCT number
NCT02097875
Sponsor
Blaze Bioscience Australia Pty Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Skin Neoplasms
Start date
2013-12-01
Primary completion
2015-03-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.